Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection - PubMed (original) (raw)
Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection
M B Graham et al. J Exp Med. 1994.
Abstract
T lymphocytes play a primary role in recovery from viral infections and in antiviral immunity. Although viral-specific CD8+ and CD4+ T cells have been shown to be able to lyse virally infected targets in vitro and promote recovery from lethal infection in vivo, the role of CD4+ T lymphocytes and their mechanism(s) of action in viral immunity are not well understood. The ability to further dissect the role that CD4+ T cells play in the immune response to a number of pathogens has been greatly enhanced by evidence for more extensive heterogeneity among the CD4+ T lymphocytes. To further examine the role of CD4+ T cells in the immune response to influenza infection, we have generated influenza virus-specific CD4+ T cell clones from influenza-primed BALB/c mice with differential cytokine secretion profiles that are defined as T helper type 1 (Th1) clones by the production of interleukin 2 (IL-2) and interferon gamma (IFN-gamma), or as Th2 clones by the production of IL-4, IL-5, and IL-10. Our studies have revealed that Th1 clones are cytolytic in vitro and protective against lethal challenge with virus in vivo, whereas Th2 clones are noncytolytic and not protective. Upon further evaluation of these clonal populations we have shown that not only are the Th2 clones nonprotective, but that pulmonary pathology is exacerbated as compared with control mice as evidenced by delayed viral clearance and massive pulmonary eosinophilia. These data suggest that virus-specific CD4+ T cells of the Th2 subset may not play a primary role in virus clearance and recovery and may lead to immune mediated potentiation of injury.
Similar articles
- Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice.
Nguyen HH, van Ginkel FW, Vu HL, Novak MJ, McGhee JR, Mestecky J. Nguyen HH, et al. J Virol. 2000 Jun;74(12):5495-501. doi: 10.1128/jvi.74.12.5495-5501.2000. J Virol. 2000. PMID: 10823854 Free PMC article. - Murine CD4+ T cell clones vary in function in vitro and in influenza infection in vivo.
Taylor PM, Esquivel F, Askonas BA. Taylor PM, et al. Int Immunol. 1990;2(4):323-8. doi: 10.1093/intimm/2.4.323. Int Immunol. 1990. PMID: 2278991 Free PMC article. - Memory CD4 T cell-mediated immunity against influenza A virus: more than a little helpful.
McKinstry KK, Dutton RW, Swain SL, Strutt TM. McKinstry KK, et al. Arch Immunol Ther Exp (Warsz). 2013 Oct;61(5):341-53. doi: 10.1007/s00005-013-0236-z. Epub 2013 May 25. Arch Immunol Ther Exp (Warsz). 2013. PMID: 23708562 Free PMC article. Review. - Role of the B-cell response in recovery of mice from primary influenza virus infection.
Gerhard W, Mozdzanowska K, Furchner M, Washko G, Maiese K. Gerhard W, et al. Immunol Rev. 1997 Oct;159:95-103. doi: 10.1111/j.1600-065x.1997.tb01009.x. Immunol Rev. 1997. PMID: 9416505 Review.
Cited by
- T-Cell Immune Responses to SARS-CoV-2 Infection and Vaccination.
Notarbartolo S. Notarbartolo S. Vaccines (Basel). 2024 Sep 30;12(10):1126. doi: 10.3390/vaccines12101126. Vaccines (Basel). 2024. PMID: 39460293 Free PMC article. Review. - MINCLE and TLR9 agonists synergize to induce Th1/Th17 vaccine memory and mucosal recall in mice and non-human primates.
Woodworth JS, Contreras V, Christensen D, Naninck T, Kahlaoui N, Gallouët AS, Langlois S, Burban E, Joly C, Gros W, Dereuddre-Bosquet N, Morin J, Liu Olsen M, Rosenkrands I, Stein AK, Krøyer Wood G, Follmann F, Lindenstrøm T, Hu T, Le Grand R, Pedersen GK, Mortensen R. Woodworth JS, et al. Nat Commun. 2024 Oct 17;15(1):8959. doi: 10.1038/s41467-024-52863-9. Nat Commun. 2024. PMID: 39420177 Free PMC article. - Integrated analyses reveal CST7 and DUSP5 regulate Th2 cells differentiation to promote chronic HBV infection.
Ning G, Liao X, Jiang H. Ning G, et al. Genes Immun. 2024 Oct;25(5):423-433. doi: 10.1038/s41435-024-00296-1. Epub 2024 Sep 5. Genes Immun. 2024. PMID: 39237681 - Immunogenicity and biodistribution of lipid nanoparticle formulated self-amplifying mRNA vaccines against H5 avian influenza.
Cui X, Vervaeke P, Gao Y, Opsomer L, Sun Q, Snoeck J, Devriendt B, Zhong Z, Sanders NN. Cui X, et al. NPJ Vaccines. 2024 Aug 3;9(1):138. doi: 10.1038/s41541-024-00932-x. NPJ Vaccines. 2024. PMID: 39097672 Free PMC article. - Virus versus host: influenza A virus circumvents the immune responses.
Su G, Chen Y, Li X, Shao JW. Su G, et al. Front Microbiol. 2024 May 16;15:1394510. doi: 10.3389/fmicb.2024.1394510. eCollection 2024. Front Microbiol. 2024. PMID: 38817972 Free PMC article. Review.
References
- J Immunol. 1975 Feb;114(2 Pt 1):559-65 - PubMed
- J Exp Med. 1986 Apr 1;163(4):903-21 - PubMed
- Scand J Immunol. 1978;7(5):389-97 - PubMed
- J Immunol. 1979 Feb;122(2):549-54 - PubMed
- Cell Immunol. 1979 Mar 15;43(2):341-51 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials